April 25, 2022 | Vanessa McMains
![](/media/som/microsites/ihv/images/news/sajadi_mohammad.jpg)
The American Society for Clinical Investigation (ASCI) elected Mohammad Sajadi, MD, Professor of Medicine in the Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM) as a 2022 member.
The ASCI is one of the U.S.’s oldest and respected nonprofit medical honor societies that focuses on supporting research efforts, medical education, and clinical practice in their members to improve the health of all people. Its more than 3,000 members are elected for outstanding scholarly achievement.
Dr. Sajadi is one of 95 new members that was inducted into the Society at the ASCI Dinner and New Member Induction Ceremony during their annual meeting on April 8, 2022.
“I would like to congratulate Dr. Sajadi on his much-deserved election to ASCI,” said Shyam Kottilil, MBBS, PhD, Professor of Medicine at the UMSOM and Director of UMSOM’s Institute of Human Virology (IHV) Division of Clinical Care and Research. “Dr. Sajadi is an exceptional physician-scientist and has made significant contributions in the field of HIV pathogenesis through his work with people known as HIV elite controllers, or those who have HIV but never develop symptoms nor require medications. He is an astute clinician, extraordinary mentor, and a skilled researcher — all attributes for a true translational scientist.”
Dr. Sajadi’s research interests involve studying the antibody response created by the immune system to disable viruses, specifically HIV and most recently SARS-CoV-2. In particular, he has identified antibodies from HIV elite neutralizers, people who make extraordinary antibodies that disable HIV, modifying these antibodies to make them even more potent to develop potential preventatives or therapies.
“We are very happy and proud of our colleague Dr. Sajadi and pleased to see ASCI’s recognition of his work,” said Robert C. Gallo, MD, the Homer & Martha Gudelsky Distinguished Professor in Medicine at UMSOM, Co-Founder and Director of the UMSOM’s Institute of Human Virology, and Co-Founder and Chair of the Scientific Leadership Board of the Global Virus Network. “We extend our heartiest congratulations. He is most deserving of this membership.”
With a specialty in infectious diseases, Dr. Sajadi is board certified in both infectious disease and internal medicine. He attended medical school at the University of Maryland School of Medicine, and then returned later for his fellowship.
About the Institute of Human Virology
Formed in 1996 as a partnership between the State of Maryland, the City of Baltimore, the University System of Maryland, and the University of Maryland Medical System, the IHV is an institute of the University of Maryland School of Medicine and is home to some of the most globally-recognized and world-renowned experts in all of virology. The IHV combines the disciplines of basic research, epidemiology, and clinical research in a concerted effort to speed the discovery of diagnostics and therapeutics for a wide variety of chronic and deadly viral and immune disorders, most notably HIV, the virus that causes AIDS. For more information, visit ihv.org and follow us on Twitter @IHVmaryland.
Contact
Vanessa McMains
Director, Media & Public Affairs
Institute of Human Virology
University of Maryland School of Medicine
vmcmains@ihv.umaryland.edu
443-875-6099
Related stories
![](/media/som/faculty/faculty-portraits/Sajadi_Mohammad.jpg)
Wednesday, March 20, 2024
New Study Reveals Insights into Lack of Durability in COVID Antibody Response to Infections & Vaccines
Researchers at the Institute of Human Virology (IHV) at the University of Maryland School of Medicine published a new study in the Journal of Infectious Diseases investigating the short-lived antibody response following SARS-CoV-2, the virus that causes COVID.
![](/media/som/microsites/ihv/images/news/sajadi_mohammad.jpg)
Friday, January 28, 2022
The Washington Post: COVID-19 may have seasons for different temperature zones, study suggests
COVID-19 transmission may have seasonal spikes tied to temperature and humidity, increasing at different times of the year for different locations, a new study in the American Journal of Tropical Medicine and Hygiene suggests.
![](/media/som/microsites/ihv/images/news/sajadi_mohammad.jpg)
Tuesday, November 02, 2021
CNN: Johnson & Johnson's Covid-19 vaccine is 73.6% effective, according to new real-world study
In an accompanying commentary, Dr. Mohammad Sajadi of the Institute of Human Virology at the University of Maryland School of Medicine, argued that the findings are part of a growing body of work that suggests "room for improvement" with the J&J vaccine.
![](/media/som/microsites/ihv/images/news/amoroso-sajadi.jpg)
Friday, March 27, 2020
Covid-19 Is Probably Seasonal, But That’s No Reason to Relax (The Washington Post)
Mohammad Sajadi and Anthony Amoroso are associate professors of medicine at the Institute of Human Virology at the University of Maryland School of Medicine and members of the Global Virus Network. As physicians and researchers, we have spoken to doctors across the country over the past few weeks and kept hearing variations on this description of the novel coronavirus’s spread: It’s like a chemical bomb went off. One day everything seemed normal, and the next everyone became sick: patients, nurses, family members.